121 / 168
119
(
`
cr)
NOTE 28.10 LOANS AND ADVANCES IN THE NATURE OF LOANS
Particulars
Purpose
Amount outstanding as at
Maximum balance
during the year
March 31,
2015
March 31,
2014
2014-15 2013-14
i) Subsidiary company:
Atul Finserv Ltd
–
4.12
4.12
4.12
Atul Bioscence Ltd
Seed funding support as
promoters
4.30
4.30
4.30
4.30
ii) Associate company:
Amal Ltd
Pursuant to the Board for
Industrial and Financial
Reconstruction order
14.88
14.88
14.88
14.88
Corporate guarantee
Atul Europe Ltd
Facilitate trade finance
GBP 10,00,000 GBP 10,00,000
Notes:
a) Loans given to employees as per the policy of the Company are not considered.
b) The loanee did not hold any shares in the share capital of the Company.
NOTE 28.11 EMPLOYEE BENEFITS
Funded schemes
a) Defined benefit plans:
Expenses recognised for the year ended on March 31, 2015 (included in Note 25)
(
`
cr)
Particulars
2014-15
2013-14
Gratuity
Gratuity
1 Change in present value of obligation:
a) Present value of obligation at beginning of the year
41.79
41.32
b) Current service cost
2.27
1.92
c) Interest cost
3.88
3.31
d) Actuarial loss (gain)
2.13
(0.40)
e) Benefits paid
(5.63)
(4.35)
f) Present value of obligation at the end of the year
44.44
41.79
2 Change in fair value of plan assets:
a) Fair value of plan assets at beginning of the year
41.79
41.32
b) Expected return on plan assets
3.63
3.62
c) Actuarial gain
1.90
0.06
d) Contributions
2.75
1.14
e) Benefits paid
(5.63)
(4.35)
f) Fair value of plan assets at end of the year
44.44
41.79
3 Reconciliation of present value of the obligation and the fair
value of plan assets and amounts recognised in the Balance
Sheet:
a) Present value of the defined benefit obligation at the end of the year
(44.44)
(41.79)
b) Fair value of plan assets at the end of the year
44.44
41.79
c) Net liability recognised in the Balance Sheet
–
–
4 Gratuity cost recognised during the year:
a) Current service cost
2.27
1.92
b) Interest cost
3.88
3.31
c) Expected return on plan assets
(3.63)
(3.62)
d) Actuarial loss
0.23
(0.46)
e) Total expense
2.75
1.15
Notes
to the Financial Statements